Adicon Holdings Limited (HKG:9860)
6.97
-0.12 (-1.69%)
Last updated: May 14, 2025
Adicon Holdings Revenue
In the year 2024, Adicon Holdings had annual revenue of 2.91B CNY, down -11.64%. Adicon Holdings had revenue of 1.45B in the half year ending December 31, 2024, a decrease of -40.02%.
Revenue
2.91B CNY
Revenue Growth
-11.64%
P/S Ratio
1.61
Revenue / Employee
535.19K CNY
Employees
5,445
Market Cap
5.00B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.91B | -383.72M | -11.64% |
Dec 31, 2023 | 3.30B | -1.56B | -32.15% |
Dec 31, 2022 | 4.86B | 1.48B | 43.83% |
Dec 31, 2021 | 3.38B | 637.78M | 23.26% |
Dec 31, 2020 | 2.74B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 32.49B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
Alibaba Health Information Technology | 31.39B |
Akeso | 2.26B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |